Tech Company Financing Transactions

Alamar Biosciences Funding Round

On 2/27/2024, Alamar Biosciences raised $128 million in Series C funding from Sands Capital Management and private investors.

Transaction Overview

Company Name
Announced On
2/27/2024
Transaction Type
Venture Equity
Amount
$128,000,000
Round
Series C
Investors

Sands Capital Management (Lead Investor) (Ian Ratcliffe)

Proceeds Purpose
The company intends to use the funds to grow the commercial and customer support teams, drive market adoption, and expand the product line.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
46421 Landing Pkwy.
Fremont, CA 94538
USA
Email Address
Overview
We are creating the most sensitive proteomics platform that can profile thousands of proteins simultaneously from as little as one microliter of plasma. Our fully automated, high throughput platform will unmask new biomarkers for early detection and prevention of common diseases and advance human health.
Profile
Alamar Biosciences LinkedIn Company Profile
Social Media
Alamar Biosciences Company Twitter Account
Company News
Alamar Biosciences News
Facebook
Alamar Biosciences on Facebook
YouTube
Alamar Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Yuling Luo
  Yuling Luo LinkedIn Profile  Yuling Luo Twitter Account  Yuling Luo News  Yuling Luo on Facebook
Chief Financial Officer
Tod White
  Tod White LinkedIn Profile  Tod White Twitter Account  Tod White News  Tod White on Facebook
Chief Operating Officer
Steve Chen
  Steve Chen LinkedIn Profile  Steve Chen Twitter Account  Steve Chen News  Steve Chen on Facebook
Chief Technical Officer
Xiao-Jun Ma
  Xiao-Jun Ma LinkedIn Profile  Xiao-Jun Ma Twitter Account  Xiao-Jun Ma News  Xiao-Jun Ma on Facebook
VP - Engineering
Yiyuan Yin
  Yiyuan Yin LinkedIn Profile  Yiyuan Yin Twitter Account  Yiyuan Yin News  Yiyuan Yin on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/27/2024: FamilyWell venture capital transaction
Next: 2/27/2024: Glean Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary